
The application is based on positive results from the ASCEND phase 3 clinical trial, assessing the efficacy and safety of daprodustat for the treatment of anemia from chronic kidney disease.

The application is based on positive results from the ASCEND phase 3 clinical trial, assessing the efficacy and safety of daprodustat for the treatment of anemia from chronic kidney disease.

Evusheld has been found to significantly reduce the risk of developing symptomatic COVID-19.

Analysis indicates that quitting provides roughly the same benefit as taking 3 medications together.

US segment to hit $121.8 billion in 2022, notes market research firm.

Among Black and Latina women with heart failure, negative health outcomes are magnified due to significant health disparities and inequities in the management of the chronic condition.

Premsyn PMS temporarily relieves symptoms associated with premenstrual syndrome.

Proactive retention strategies can improve employee satisfaction and reduce turnover rates.

Sonia Oskouei, PharmD, vice president of biosimilars at Cardinal Health, discusses what biosimilars in the pipeline are expected to launch this year.

Asthma contributed most to the risk of high blood pressure and coronary heart disease.

Among individuals taking the medication with standard-of-care topical corticosteroids, approximately 41% achieved clear or almost clear skin at 16 weeks.

Sonia Oskouei, PharmD, vice president of biosimilars at Cardinal Health, on the results of Cardinal Health’s assessment of the current biosimilars market published in the 2022 Biosimilars Report.

Although the ISMP created the guidelines for hospitals, they are applicable in other health care settings.

The phase 3, multicenter, randomized, double-blinded, comparative clinical study was evaluating the efficacy and safety of ABP 654 compared with ustekinumab in adult patients with moderate to severe plaque psoriasis.

When states legalize marijuana, the volume of prescriptions within the drug classes that align with the medical indications for pain, depression, anxiety, sleep, psychosis, and seizures significantly decline.

Quiz questions to assess your knowledge on common treatments for cold sores.

Haloperidol (Haldol) is indicated for use in the treatment of schizophrenia and to control the symptoms of Tourette's disorder, as well as severe behavioral problems or hyperactivity in children.

Zantac can treat and prevent heartburn, as well as treating stomach ulcers, gastroesophageal reflux disease, and conditions that cause too much stomach acid.

Heart-related complications in children with COVID-19 are uncommon, but case reports have noted cardiogenic shock, myocarditis, pericarditis, and arrhythmias.

David Pope, PharmD, CDE, chief innovation officer at OmniSYS, discusses some of the technology trends that occurred in the pharmacy space during the pandemic.

In this month's episode, Staci Rush, clinical pharmacy technician at Hometown Pharmacy, discusses pharmacy intervention and how it can reduce hospital readmissions for patients.

Invega Hafyera is an atypical antipsychotic indicated for the treatment of schizophrenia in adults.

Theraful is a cold and flu medication that may help to relieve symptoms such as congestion, sore throat, aching, and fever.

Rita Roy, MD, CEO of the National Spine Health Foundation, discusses some alternative treatment plans for chronic back pain to help address the opioid epidemic.

Eptinezumab is a calcitonin gene-related peptide antagonist FDA-approved for the preventive treatment of migraine.

Mylo Wells, PharmD, owner of Wells Hometown Drug and Wells Hometown Drug Keosauqua, aims to give back to the community where he grew up.

PrEP use has been associated with lowering HIV infections worldwide, however use of the treatment alone is not sufficient to prevent HIV from spreading.

Loratadine is an antihistamine that treats symptoms of allergies such as itching, runny nose, watery eyes, and sneezing.

New research may offer pharmacists a better means of helping customers manage the symptoms of an alcohol hangover.

Lack of acknowledgement or rewards in high-pressure pharmacy environments can lead to mental health issues.

Cabotegravir is the only current HIV-1 PrEP medication that does need to be taken daily.